These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30082544)

  • 1. Clinicoepidemiological profiles, clinical practices, and the impact of holistic care interventions on outcomes of pediatric hematolymphoid malignancies - A 7-year audit of the pediatric hematolymphoid disease management group at Tata Memorial Hospital.
    Narula G; Prasad M; Jatia S; Subramanian PG; Patkar N; Tembhare P; Shetty D; Khanna N; Laskar S; Shet T; Epari S; Kembhavi S; Shah S; Qureshi S; Gujral S; Banavali SD
    Indian J Cancer; 2017; 54(4):609-615. PubMed ID: 30082544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term clinical outcomes of adult hematolymphoid malignancies treated at Tata Memorial Hospital: An institutional audit.
    Khattry N; Laskar S; Sengar M; Rangarajan V; Shet T; Subramanian PG; Epari S; Bagal B; Goda JS; Agarwal A; Jain H; Tembhare P; Patkar N; Khanna N; Punatar S; Gokarn A; Shetty D; Jain H; Bonda A; Gota V; Hasan S; Kode J; Dutt S; Kulkarni S; Shetty N; Sable N; Deodhar J; Jadhav S; Pawaskar P; Mathew L; Menon H; Nair R; Kannan S; Chiplunkar S; Gujral S
    Indian J Cancer; 2018; 55(1):9-15. PubMed ID: 30147087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Incidence of neoplasms of the hematologic and lymphoreticular systems in Lower Silesia 1972-1985. I. Incidence in the entire region].
    Kotlarek-Haus S; Waszkiewicz L; Kin-Dittmann I; Błaczkowska A
    Acta Haematol Pol; 1990; 21(2):173-84. PubMed ID: 2131717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century.
    Pulte D; Jansen L; Brenner H
    Blood Cancer J; 2020 May; 10(5):56. PubMed ID: 32404891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage at diagnosis for children with blood cancers in Australia: Application of the Toronto Paediatric Cancer Stage Guidelines in a population-based national childhood cancer registry.
    Youlden DR; Gupta S; Frazier AL; Moore AS; Baade PD; Valery PC; Green AC; Aitken JF
    Pediatr Blood Cancer; 2019 Jun; 66(6):e27683. PubMed ID: 30803139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of childhood leukemia in Hokkaido, Japan.
    Nishi M; Miyake H; Takeda T; Shimada M
    Int J Cancer; 1996 Jul; 67(3):323-6. PubMed ID: 8707403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Leukemias and malignant lymphomas in children].
    Schmiegelow K
    Ugeskr Laeger; 1999 Apr; 161(15):2191-5. PubMed ID: 10222813
    [No Abstract]   [Full Text] [Related]  

  • 8. Dasatinib in children and adolescents with relapsed or refractory leukemia: results of the CA180-018 phase I dose-escalation study of the Innovative Therapies for Children with Cancer Consortium.
    Zwaan CM; Rizzari C; Mechinaud F; Lancaster DL; Lehrnbecher T; van der Velden VH; Beverloo BB; den Boer ML; Pieters R; Reinhardt D; Dworzak M; Rosenberg J; Manos G; Agrawal S; Strauss L; Baruchel A; Kearns PR
    J Clin Oncol; 2013 Jul; 31(19):2460-8. PubMed ID: 23715577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in leukemia incidence and survival in the United States (1973-1998).
    Xie Y; Davies SM; Xiang Y; Robison LL; Ross JA
    Cancer; 2003 May; 97(9):2229-35. PubMed ID: 12712476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Family history of cancer in children with acute leukemia, Hodgkin's lymphoma or non-Hodgkin's lymphoma: the ESCALE study (SFCE).
    Rudant J; Menegaux F; Leverger G; Baruchel A; Nelken B; Bertrand Y; Hartmann O; Pacquement H; Vérité C; Robert A; Michel G; Margueritte G; Gandemer V; Hémon D; Clavel J
    Int J Cancer; 2007 Jul; 121(1):119-26. PubMed ID: 17330239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical management of Australian adolescents and young adults with acute lymphoblastic and myeloid leukemias: A national population-based study.
    White VM; Skaczkowski G; Pinkerton R; Coory M; Osborn M; Bibby H; Nicholls W; Orme LM; Conyers R; Phillips MB; Harrup R; Walker R; Thompson K; Anazodo A
    Pediatr Blood Cancer; 2018 Nov; 65(11):e27349. PubMed ID: 30039912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukemia and lymphoma incidence in children in Alberta, Canada: a population-based 22-year retrospective study.
    Kulkarni K; Stobart K; Witol A; Rosychuk RJ
    Pediatr Hematol Oncol; 2011 Nov; 28(8):649-60. PubMed ID: 21981741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal smoking and childhood leukemia and lymphoma risk among 1,440,542 Swedish children.
    Mucci LA; Granath F; Cnattingius S
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1528-33. PubMed ID: 15342456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in survival of leukemia among children, adolescents, and young adults: A population-based study in Osaka, Japan.
    Nakata K; Okawa S; Fuji S; Sato A; Morishima T; Tada Y; Inoue M; Hara J; Kawa K; Miyashiro I;
    Cancer Sci; 2021 Mar; 112(3):1150-1160. PubMed ID: 33428808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns and temporal trends in the incidence of malignant disease in children: I. Leukaemia and lymphoma.
    Blair V; Birch JM
    Eur J Cancer; 1994; 30A(10):1490-8. PubMed ID: 7833108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes among pediatric patients with cancer who are treated on trial versus off trial: A matched cohort study.
    Schapira MM; Stevens EM; Sharpe JE; Hochman L; Reiter JG; Calhoun SR; Shah SA; Bailey LC; Bagatell R; Silber JH; Tai E; Barakat LP
    Cancer; 2020 Aug; 126(15):3471-3482. PubMed ID: 32453441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of allogeneic peripheral blood stem cell transplantation by donor graft CD3+/Tregs ratio: a single-center experience.
    Delia M; Pastore D; Mestice A; Carluccio P; Perrone T; Gaudio F; Ricco A; Sgherza N; Albano F; Specchia G
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):495-9. PubMed ID: 23200706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consistent genetic abnormalities in human cancers as targets for selective therapies.
    Clarkson BD
    Mt Sinai J Med; 1992 Oct; 59(5):400-4. PubMed ID: 1435835
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence and risk of leukemia in the multi-ethnic population of North Karnataka.
    Modak H; Kulkarni SS; Kadakol GS; Hiremath SV; Patil BR; Hallikeri U; Gai PB
    Asian Pac J Cancer Prev; 2011; 12(3):671-5. PubMed ID: 21627362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.